Colgate-Palmolive Company
Every calculator, already run for CL
Open the full toolkit →You have the numbers on CL. Get the argument.
A written report on which of these readings actually decide the outcome for Colgate-Palmolive Company, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
21 analysts covering CLAnalyst Price Target Disagreement for Colgate-Palmolive Company
Wall Street's bull case implies +26% from the current price; the bear case implies -1%. Analysts are relatively aligned on CL's range.
Ownership & short interest
Insider Trading Activity for CL
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA…
CL — frequently asked
Is CL a buy right now?
Wall Street's consensus rating on Colgate-Palmolive Company is Buy across 21 analysts, with a mean price target of $98.95 (+13% vs. the current $87.47). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is CL overvalued?
CL trades at 34.4x trailing earnings, against a DCF fair value of $168 per share. The current price implies -2% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is CL's next earnings date?
Colgate-Palmolive Company is next scheduled to report earnings around Oct 30, 2026. A full CL research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Colgate-Palmolive Company?
Analysts covering Colgate-Palmolive Company (CL) range from a bear-case target of $87.00 to a bull-case high of $110.00, with a mean consensus target of $98.95 across 20 analysts. The spread of $23.00 (26% of the current price) indicates moderate disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Colgate-Palmolive Company against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Colgate-Palmolive Company
Start with the evergreen guides that matter most for Consumer Defensive, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full CL research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Colgate-Palmolive Company, in minutes. 3 free reports included with every account — no credit card required.